[Prophylactic cranial irradiation for limited-stage small cell lung cancer: controversies and advances].
作者信息
Hu Xiao, Chen Ming
机构信息
Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China.
出版信息
Zhongguo Fei Ai Za Zhi. 2013 Jul;16(7):373-7. doi: 10.3779/j.issn.1009-3419.2013.07.08.
Abstract
摘要
相似文献
1
[Prophylactic cranial irradiation for limited-stage small cell lung cancer: controversies and advances].
Zhongguo Fei Ai Za Zhi. 2013 Jul;16(7):373-7. doi: 10.3779/j.issn.1009-3419.2013.07.08.
2
Should all patients with SCLC receive prophylactic cranial irradiation if they have responded to treatment? PCI should be offered in nearly all cases.
Clin Adv Hematol Oncol. 2015 Nov;13(11):729-31.
3
Should all patients with SCLC receive prophylactic cranial irradiation if they have responded to treatment? The time has come to improve on a former standard.
Clin Adv Hematol Oncol. 2015 Nov;13(11):729, 732-3.
4
Redefining the Role of Prophylactic Cranial Irradiation in the Modern Era of Active Surveillance in Small Cell Lung Cancer.
JAMA Oncol. 2019 Jan 1;5(1):11-12. doi: 10.1001/jamaoncol.2018.4833.
5
Prophylactic Cranial Irradiation in Resected Small Cell Lung Cancer: Comprehensive Staging, Adjuvant Chemotherapy, and Strict Stratification of Pathological Stage Play a Role.
J Thorac Oncol. 2017 Sep;12(9):e137-e138. doi: 10.1016/j.jtho.2017.03.021.
6
In regards to Chu et al.: Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.
Radiat Oncol. 2020 Nov 2;15(1):252. doi: 10.1186/s13014-020-01680-7.
7
The Road Less Traveled: Should We Omit Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer?
Clin Lung Cancer. 2018 Jul;19(4):289-293. doi: 10.1016/j.cllc.2018.03.006. Epub 2018 Mar 16.
8
Prophylactic cranial irradiation: the state of the art and areas of uncertainty.
Clin Transl Oncol. 2012 Apr;14(4):317-9. doi: 10.1007/s12094-012-0801-7.
9
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts.
Radiother Oncol. 2019 Apr;133:163-166. doi: 10.1016/j.radonc.2018.12.014. Epub 2019 Jan 31.
10
Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiation.
Radiother Oncol. 2017 Oct;125(1):130-135. doi: 10.1016/j.radonc.2017.07.019. Epub 2017 Aug 1.
引用本文的文献
1
Association of Twice-Daily Radiotherapy With Subsequent Brain Metastases in Adults With Small Cell Lung Cancer.
JAMA Netw Open. 2019 May 3;2(5):e190103. doi: 10.1001/jamanetworkopen.2019.0103.
2
Risk factors for brain metastases after prophylactic cranial irradiation in small cell lung cancer.
Sci Rep. 2017 Feb 16;7:42743. doi: 10.1038/srep42743.
本文引用的文献
1
Factors affecting the risk of brain metastasis in small cell lung cancer with surgery: is prophylactic cranial irradiation necessary for stage I-III disease?
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):196-200. doi: 10.1016/j.ijrobp.2012.03.038. Epub 2012 Jul 17.
2
Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis.
Ann Oncol. 2012 Nov;23(11):2919-2924. doi: 10.1093/annonc/mds123. Epub 2012 Jul 10.
3
Omitting elective nodal irradiation and irradiating postinduction versus preinduction chemotherapy tumor extent for limited-stage small cell lung cancer: interim analysis of a prospective randomized noninferiority trial.
Cancer. 2012 Jan 1;118(1):278-87. doi: 10.1002/cncr.26119. Epub 2011 May 19.
4
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
Ann Oncol. 2011 May;22(5):1154-1163. doi: 10.1093/annonc/mdq576. Epub 2010 Dec 7.
5
Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):77-84. doi: 10.1016/j.ijrobp.2010.05.013. Epub 2010 Aug 26.
6
Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy.
Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1244-52. doi: 10.1016/j.ijrobp.2010.01.039.
7
Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933.
Radiother Oncol. 2010 Jun;95(3):327-31. doi: 10.1016/j.radonc.2010.02.030. Epub 2010 Apr 12.
8
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
Lancet Oncol. 2009 May;10(5):467-74. doi: 10.1016/S1470-2045(09)70101-9. Epub 2009 Apr 20.
9
Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
Cancer. 2009 Feb 15;115(4):842-50. doi: 10.1002/cncr.24105.
10
Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience.
J Thorac Oncol. 2008 Jun;3(6):652-5. doi: 10.1097/JTO.0b013e3181757a76.
Zotero 插件